CommentaryClinical Trials

A Virtual National Laboratory for Reengineering Clinical Translational Science

See allHide authors and affiliations

Science Translational Medicine  25 Jan 2012:
Vol. 4, Issue 118, pp. 118cm2
DOI: 10.1126/scitranslmed.3002951


Clinical research is burdened by inefficiencies and complexities, with a poor record of trial completion, none of which is desirable. The Clinical and Translational Science Award (CTSA) Consortium, including more than 60 clinical research institutions, supports a unified national effort to become, in effect, a virtual national laboratory designed to identify, implement, evaluate, and extend process improvements across all parts of clinical research, from conception to completion. If adequately supported by academic health centers, industry, and funding agencies, the Consortium could become a test bed for improvements that can dramatically reduce wasteful complexity, thus increasing the likelihood of clinical trial completion.

View Full Text

Stay Connected to Science Translational Medicine